Literature DB >> 34060028

Myxobacteria and their products: current trends and future perspectives in industrial applications.

Akansha Shrivastava1, Rakesh Kumar Sharma2.   

Abstract

Myxobacteria belong to a group of bacteria that are known for their well-developed communication system and synchronized or coordinated movement. This typical behavior of myxobacteria is mediated through secondary metabolites. They are capable of producing secondary metabolites belonging to several chemical classes with unique and wide spectrum of bioactivities. It is predominantly significant that myxobacteria specialize in mechanisms of action that are very rare with other producers. Most of the metabolites have been explored for their medical and pharmaceutical values while a lot of them are still unexplored. This review is an attempt to understand the role of potential metabolites produced by myxobacteria in different applications. Different myxobacterial metabolites have demonstrated antibacterial, antifungal, and antiviral properties along with cytotoxic activity against various cell lines. Beside their metabolites, these myxobacteria have also been discussed for better exploitation and implementation in different industrial sectors.

Year:  2021        PMID: 34060028     DOI: 10.1007/s12223-021-00875-z

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  69 in total

1.  Total synthesis of chivosazole F.

Authors:  Tobias Brodmann; Dominic Janssen; Markus Kalesse
Journal:  J Am Chem Soc       Date:  2010-10-06       Impact factor: 15.419

2.  Feruloyl esterases as a tool for the release of phenolic compounds from agro-industrial by-products.

Authors:  Isabelle Benoit; David Navarro; Nathalie Marnet; Nnjara Rakotomanomana; Laurence Lesage-Meessen; Jean-Claude Sigoillot; Marcel Asther; Michèle Asther
Journal:  Carbohydr Res       Date:  2006-05-15       Impact factor: 2.104

3.  Vitiosangium cumulatum gen. nov., sp. nov. and Vitiosangium subalbum sp. nov., soil myxobacteria, and emended descriptions of the genera Archangium and Angiococcus, and of the family Cystobacteraceae.

Authors:  Ram Prasad Awal; Ronald Garcia; Katja Gemperlein; Joachim Wink; Bikram Kunwar; Niranjan Parajuli; Rolf Müller
Journal:  Int J Syst Evol Microbiol       Date:  2017-06-05       Impact factor: 2.747

4.  Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library.

Authors:  Simon Beck; Lisa Henß; Tatjana Weidner; Jennifer Herrmann; Rolf Müller; Yu-Kai Chao; Christian Grimm; Christopher Weber; Katja Sliva; Barbara S Schnierle
Journal:  Antiviral Res       Date:  2016-05-27       Impact factor: 5.970

Review 5.  In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites.

Authors:  Chantal D Bader; Fabian Panter; Rolf Müller
Journal:  Biotechnol Adv       Date:  2019-11-07       Impact factor: 14.227

6.  Interactions Between Myxobacteria, Plant Pathogenic Fungi, and Biocontrol Agents.

Authors:  C T Bull; K G Shetty; K V Subbarao
Journal:  Plant Dis       Date:  2002-08       Impact factor: 4.438

Review 7.  Preclinical investigations with epothilones in breast cancer models.

Authors:  Howard A Burris
Journal:  Semin Oncol       Date:  2008-04       Impact factor: 4.929

8.  Supercritical Fluid Extraction Enhances Discovery of Secondary Metabolites from Myxobacteria.

Authors:  Chantal D Bader; Markus Neuber; Fabian Panter; Daniel Krug; Rolf Müller
Journal:  Anal Chem       Date:  2020-11-10       Impact factor: 6.986

9.  Racemicystis crocea gen. nov., sp. nov., a soil myxobacterium in the family Polyangiaceae.

Authors:  Ram Prasad Awal; Ronald Garcia; Rolf Müller
Journal:  Int J Syst Evol Microbiol       Date:  2016-04-05       Impact factor: 2.747

10.  Myxobacteria-mediated synthesis of silver nanoparticles and their impregnation in wrapping paper used for enhancing shelf life of apples.

Authors:  Swati Bhople; Swapnil Gaikwad; Swapna Deshmukh; Shital Bonde; Aniket Gade; Sanjib Sen; Anna Brezinska; Hanna Dahm; Mahendra Rai
Journal:  IET Nanobiotechnol       Date:  2016-12       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.